Testing fluid removal through the belly in heart-kidney failure
Part of Heart & circulation clinical trials.
This trial studies a treatment that removes extra fluid through a catheter placed in the abdomen (peritoneal ultrafiltration) for people with “cardio-renal syndrome” (heart and kidney problems together). It may help those who stay congested despite high-dose water pills (diuretics) and have certain heart circulation and fluid signs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your heart pumping strength is reduced (left side ejection fraction 60% or less)
- You have serious ongoing shortness of breath/fatigue from heart failure (NYHA class III–IV) despite standard medicines
- You have signs of right-sided heart strain and fluid overload, confirmed by a heart pressure test (right heart catheterization) after stable meds
- Your kidneys are not in end-stage failure (measured kidney filtration needs to be above a cutoff)
- You have needed high-dose IV diuretics for congestion at least once in the last 6 months, showing the usual water pills may not be working
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using belly pressure and bedside ultrasound can help doctors better manage fluid removal (decongestion) in people hospitalized with heart failure. The goal is to see if this approach leads to better outcomes.
This study tests a new way to guide fluid removal (decongestive therapy) in people hospitalized for heart failure. It aims to help doctors safely reduce fluid buildup, no matter what type of heart failure you have.
This study is testing whether belly and chest ultrasounds can help doctors better manage fluid removal in people with worsening heart failure. It may help your care team adjust your treatment to make you feel better faster.
This trial tests a device to help the kidneys remove excess fluid in people hospitalized for worsening heart failure who are not responding well to standard diuretic (water pill) therapy. It aims to improve heart and kidney function.
This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).
This trial tests a wearable device that removes extra fluid from your body without using the kidneys. It may help people with heart failure who still have fluid buildup despite taking high doses of water pills.
Hear when a new Congestive Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.